http://finance.yahoo.com/q?s=bota
BIOTA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues Investigation of Biota Pharmaceuticals, Inc.; Investors Encouraged to Contact the Firm
Count me in!!!
It was a big decision on my part to stick with BTA as it deserted Australia and listed on the NASDAQ. The ONLY reason I stuck with this perennial underperformer was the utterances of our board. And then they messed up big time.
Funny how Daiichi Sanko can make a success of our product but success eluded Fox, Cook and co.
